UnitedHealth Group Incorporated (UNH)
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally.
Scored against other Healthcare stocks, not a fixed scale.
The quick read
UnitedHealth Group reads as neutral right now, with no clear lean either way.
- What's working
- Its price has held up well, trading above its recent averages.
- Worth watching
- It carries more debt, or less cash, than most other healthcare companies.
Analyst price target
~12-month · 25 analystsPublished targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare…
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Employees
- 390,000
- Headquarters
- Eden Prairie, MN
Similar stocks
What’s behind the score
Valuation
P/E 25.8 — lower than 64% of Healthcare peers
P/B 3.5 — lower than 54% of Healthcare peers
P/S 0.8 — lower than 83% of Healthcare peers
EV/EBITDA 14.2 — lower than 50% of Healthcare peers
EV/Revenue 0.9 — lower than 83% of Healthcare peers
PEG 1.1 — lower than 78% of Healthcare peers
FCF yield 7.4% — higher than 90% of Healthcare peers
Profitability & quality
Gross margin 20.0% — higher than 17% of Healthcare peers
Operating margin 5.8% — higher than 23% of Healthcare peers
Net margin 3.5% — higher than 23% of Healthcare peers
ROE 15.8% — higher than 67% of Healthcare peers
ROA 5.2% — higher than 41% of Healthcare peers
Free cash flow is 167% of reported net income
Financial health
Debt/equity 0.7 — lower than 37% of Healthcare peers
Current ratio 0.74 — higher than 3% of Healthcare peers
Quick ratio 0.42 — higher than 7% of Healthcare peers
Cash/debt 0.38 — higher than 72% of Healthcare peers
Debt/EBITDA 2.57 — lower than 38% of Healthcare peers
Growth
Revenue growth -0.4% YoY — higher than 3% of Healthcare peers
Earnings growth 75.9% YoY — higher than 88% of Healthcare peers
Ownership & investor activity
Payout ratio 57.6% — somewhat unusual vs Healthcare peers
Net insider buying, +0.1% of insider shares
Institutions net sold, -12.0% of shares held
Insiders hold 0.2% of shares outstanding
2.0% of float sold short
Momentum
Above its 50- & 200-day averages
71% of the way from its 52-week low to high